Table 2. Effect of lymphocytotoxicity... | American Society of Hematology

Table 2.

Effect of lymphocytotoxicity screening assay on platelet increments 1 hour after granulocyte transfusions

Transplant day of component transfusion	Component cell dose (×10¹¹)^*				Absolute platelet increment (×10³/μL)^*				CCI (×10³/μL)^*
Transplant day of component transfusion	Overall	s-LCA negative	s-LCA positive	P^†	Overall	s-LCA negative	s-LCA positive	P^‡	Overall	s-LCA negative	s-LCA positive	P^‡
+2	4.1 (2.6-6.2)	4.0 (2.6-6.2)	4.2 (2.9-5.9)	0.73	14 (0-49)	11 (0-20)	15 (0-49)	0.99	6.5 (0-24.6)	5.5 (0-12.1)	6.8 (0-24.6)	0.77
+4	3.3 (1.5-5.0)	3.3 (1.5-5.0)	3.1 (2.5-4.1)	0.68	12 (0-59)	8 (0-22)	18 (0-59)	0.20	7.6 (0-39.5)	5.2 (0-20.7)	11.6 (0-39.5)	0.32
+6	2.7 (2.1-3.6)	2.7 (2.1-3.6)	2.6 (2.1-3.1)	0.74	8 (0-21)	10 (0-21)	5 (0-11)	0.21	6.8 (0-35.0)	6.3 (0-14.4)	7.8 (0-35.0)	0.33
+8	2.4 (1.5-3.0)	2.2 (1.5-2.8)	2.5 (1.8-3.0)	0.36	8 (0-16)	7 (0-16)	10 (7-13)	0.24	6.8 (0-15.1)	6.0 (0-15.1)	7.8 (4.3-10.2)	0.30

Transplant day of component transfusion	Component cell dose (×10¹¹)^*				Absolute platelet increment (×10³/μL)^*				CCI (×10³/μL)^*
Transplant day of component transfusion	Overall	s-LCA negative	s-LCA positive	P^†	Overall	s-LCA negative	s-LCA positive	P^‡	Overall	s-LCA negative	s-LCA positive	P^‡
+2	4.1 (2.6-6.2)	4.0 (2.6-6.2)	4.2 (2.9-5.9)	0.73	14 (0-49)	11 (0-20)	15 (0-49)	0.99	6.5 (0-24.6)	5.5 (0-12.1)	6.8 (0-24.6)	0.77
+4	3.3 (1.5-5.0)	3.3 (1.5-5.0)	3.1 (2.5-4.1)	0.68	12 (0-59)	8 (0-22)	18 (0-59)	0.20	7.6 (0-39.5)	5.2 (0-20.7)	11.6 (0-39.5)	0.32
+6	2.7 (2.1-3.6)	2.7 (2.1-3.6)	2.6 (2.1-3.1)	0.74	8 (0-21)	10 (0-21)	5 (0-11)	0.21	6.8 (0-35.0)	6.3 (0-14.4)	7.8 (0-35.0)	0.33
+8	2.4 (1.5-3.0)	2.2 (1.5-2.8)	2.5 (1.8-3.0)	0.36	8 (0-16)	7 (0-16)	10 (7-13)	0.24	6.8 (0-15.1)	6.0 (0-15.1)	7.8 (4.3-10.2)	0.30

Mean (range).

t test.

Mann-Whitney U test.